ZAC基因在奥曲肽抑制胃癌细胞体外增殖通路的作用
Role of ZAC gene in the pathway of octreotide inhibiting proliferation of gastric cancer cells in vitro
目的 探讨ZAC基因在生长抑素类似物奥曲肽(OCT)抑制胃癌细胞增殖通路的作用。方法 分别以不同浓度OCT处理胃癌细胞BGC823和 SGC7901不同时间,MTT法筛选其增殖抑制的有效条件。OCT处理胃癌细胞(有效浓度/不同时间,有效时间/不同浓度),Western blotting检测
OCT对胃癌细胞ZAC基因的效应。设计3条ZAC基因RNA干扰片段,分别插入pSUPER-EGFP-I载体,构建3个ZAC-shRNA表达载体(pSUPER-EGFP-ZAC/1 pSUPER-EGFP-ZAC/2和pSUPER-EGFP-ZAC/3)。经酶切和序列分析鉴定后,分别转染胃癌细胞BGC823和SGC7901。经G418筛选,RT-PCR鉴定,建立
ZAC基因敲低(knock-down)的胃癌细胞系。以有效条件OCT孵育胃癌细胞(对照组)和ZAC基因敲低胃癌细胞(实验组),MTT法检测OCT对胃癌 细胞的生长抑制效应。结果 OCT抑制胃癌细胞增殖的有效条件为10nmol/L 孵育24h;OCT以时间和浓度依赖的方式诱导胃癌细胞ZAC基因表达。酶切及序列分析鉴定表明ZAC-shRNA表达载体构建成功。转染shRNA-ZAC/2的胃癌细胞,其ZAC mRNA水平明显降低(P<0.05),为ZAC基因敲低胃癌 细胞。ZAC基因敲低胃癌细胞的增殖明显高于对应的BGC823细胞和SGC7901细胞(P<0.05)。OCT孵育后,BGC823细胞和SGC7901细胞的增殖明显降低(P<0.05)。然而,ZAC基因敲低胃癌细胞的增殖无明显改变(P>0.05)。结论 OCT以时间和浓度依赖的方式诱导胃癌细胞ZAC基因表达;ZAC 基因在OCT抑制胃癌细胞增殖通路中具有重要作用。
Objective To explore the role of ZAC gene in the pathway of somatostatin analogue, octreotide (OCT), inhibiting proliferation of gastric cancer cells. Methods The gastric cancer cells BGC823 and SGC7901 were treated with OCT at various concentrations for various times, respectively. MTT assay was used to screen effective condition of OCT for its antiproliferative action. After treatment with OCT (effective concentration/various times, effective time/various concentrations), the inducing effect of OCT on ZAC gene expression in gastric cancer cells was detected by Western blotting. Three fragments for ZAC gene RNA interference were inserted into pSUPER-EGFP-I vector to construct ZAC-shRNA expression vectors (pSUPER-EGFP-ZAC/1, pSUPER-EGFP-ZAC/2 and pSUPER-EGFP-ZAC/3), respectively. After identification by Hind Ⅲ/EcoRⅠdigestion and sequencing, the three ZAC-shRNA expression vectors were transfected into gastric cancer cells BGC823 and SGC7901, respectively. After G418 screening and RT-PCR identification, the gastric cancer cell lines in which ZAC gene was knock-down were established. Gastric cancer cells (control group) and those in which ZAC gene was knock-down (experimental group) were incubated with OCT at effective condition, the antiproliferative action of OCT was detected by MTT assay. Results The effective condition of OCT inhibiting proliferation of gastric cancer cells was 10nmol/L and treatmented for 24 hours. OCT induced ZAC gene expression in gastric cancer cells in a time-and dose-dependant manner. The results of Hind Ⅲ/EcoRⅠ digestion and sequencing indicated that ZAC-shRNA expression vectors were constructed successfully. The ZAC mRNA level in the gastric cancer cells transfected with shRNA-ZAC/2 was decreased significantly (P<0.05), which were the gastric cancer cell lines in which ZAC gene was knock-down. The proliferation of the gastric cancer cell lines in which ZAC gene was knock-down was significantly higher than that of corresponding BGC823 and SGC7901 (P<0.05). After OCT incubation, the proliferation of BGC823 and SGC7901 were decreased obviously (P<0.05); however, that of the cells in which ZAC gene was knock-down did not exhibit significant changes (P>0.05). Conclusion OCT induces ZAC gene expression in gastric cancer cells in a time-and dose-dependant manner. ZAC gene may play an important role in the pathway of OCT inhibiting the proliferation of gastric cancer cells.
奥曲肽 / ZAC / 胃癌细胞 / 增殖 / RNA干扰 / 免疫印迹法
Octreotide / ZAC / Gastric cancer cell / Proliferation / RNA interference / Western blotting
[1]Abdollahi A. LOT1 (ZAC/PLAGL1) and its family members mechanisms and function[J]. J Cell Physiol, 2007, 210(1): 16-25.
[2]War SA, Kumar U. Coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosis[J]. J Mol Signal, 2012, 7(1): 5-19.
[3] Zhang GZh, Ding Y, Liu J, et al. Correlation of ZAC with somatostatin and its receptor expression in gastric cancer tissues[J]. Acta Anatomica Sinaca, 2008, 39 (5): 703-707.(in Chinese)
张广政,丁一,刘键,等.胃癌组织中ZAC与生长抑素及生长抑素受体表达的相关性[J].解剖学报,2008,39(5):703-707.
[4]Weckbecker G, Lewis I, Albert R, et al. Opportunities in somatostatin research: biological, chemical and therapeutic aspects[J]. Nat Rev Drug Discov, 2003, 2(12): 999-1017.[5]May P, May E. Twenty years of p53 research: structural and functional aspects of the p53 protein[J]. Oncogene, 1999,18 (2): 7621-7636.
[6]Shibui T, Higo Y, Tsutsui TW, et al. Changes in expression of imprinted genes following treatment of human cancer cell lines with nonmutagenic or mutagenic carcinogens[J]. Int J Oncol, 2008, 33(2): 351-360.
[7]Midorikawa Y, Yamamoto S, Ishikawa S, et al. Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays[J]. Oncogene, 2006, 25(40): 5581-5590.
[8]Qi QG, Ma J, Da G, et al. Expression of zac in esophageal squamous cell carcinoma and its clinical significance[J]. Journal of the Fourth Military Medical University, 2007,28(19): 1793-1795.(in Chinese)
祁秋干,马军, 达嘎, 等.食管鳞癌中zac基因的表达及临床意义[J]. 第四军医大学学报, 2007,28(19):1793-1795.
[9]Jarmalaite S, Laurinaviciene A, Tverkuviene J, et al. Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas[J]. Cancer Genet, 2011, 204(7): 398-404.
[10]Valleley EM, Cordery SF, Carr IM, et al. Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation[J]. Genes Chromosomes Cancer, 2010, 49(5): 480-486.
[11]Theodoropoulou M, Tichomirowa MA, Sievers C, et al. Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly[J]. Int J Cancer, 2009, 125(9): 2122-2126.
[12]Theodoropoulou M, Zhang J, Laupheimer S, et al. Octreotide, a somatastatin analogue, mediate its antiproliferative action in pituitary tumor cells by altering phosphatidylinotol 3-kinase signaling and inducing Zac1 expression[J]. Cancer Res, 2006, 66(3): 1576-1582.
[13]Wang CH, Tang CW, Liu CL, et al. Inhibitory effect of octreotide on gastric cancer growth via MAPK pathway[J]. World J Gastroenterol, 2003, 9(9): 1904-1908.
[14]El-Salhy M. Effects of octreotide, galanin and serotonin on a human gastric cancer cell line[J]. Oncol Rep, 2005, 13(5): 787-791.
[15]Theodoropoulou M, Stalla GK, Spengler D. ZAC1 target genes and pituitary tumorigenesis[J]. Mol Cell Endocrinol, 2010, 326(1-2): 60-65.
省自然科学基金资助项目
/
〈 |
|
〉 |